Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain

被引：34

作者：

Betriu, Carmen ^{[1
]}

Culebras, Esther ^{[1
]}

Gomez, Maria ^{[1
]}

Lopez, Fatima ^{[1
]}

Rodriguez-Avial, Iciar ^{[1
]}

Picazo, Juan J. ^{[1
]}

机构：

[1] Hosp Clin San Carlos, Serv Microbiol Clin, Madrid 28040, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2008年 / 52卷 / 07期

关键词：

D O I：

10.1128/AAC.00081-08

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The changes in susceptibilities of Bacteroides fragilis group strains isolated in our hospital from 1997 to 2006 were studied. A total of 1,343 clinical strains were included. The study showed differences in the resistance rates in the different species of the group. Increasing resistance to clindamycin and moxifloxacin was observed. Susceptibility to imipenem, piperacillin-tazobactam, and metronidazole remained unchanged.

引用

页码：2686 / 2690

页数：5

共 19 条

[1] Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species [J].

Aldridge, KE ;

Ashcraft, D ;

Cambre, K ;

Pierson, CL ;

Jenkins, SG ;

Rosenblatt, JE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1238-1243

[2]

[Anonymous], M11A6 NCCLS

[3] Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002) [J].

Betriu, C ;

Rodríguez-Avial, I ;

Gómez, M ;

Culebras, E ;

Picazo, JJ .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 53 (03) :221-223

[4] CHANGES IN THE SUSCEPTIBILITY OF BACTEROIDES-FRAGILIS GROUP ORGANISMS TO VARIOUS ANTIMICROBIAL AGENTS 1979-1989 [J].

BETRIU, C ;

CABRONERO, C ;

GOMEZ, M ;

PICAZO, JJ .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (04) :352-356

[5]

Clinical and Laboratory Standards Institute (CLSI), 2007, M11A7 CLSI

[6] Emergence of fluoroquinolone resistance among Bacteroides species [J].

Golan, Y ;

McDermott, LA ;

Jacobus, NV ;

Goldstein, EJC ;

Finegold, S ;

Harrell, LJ ;

Hecht, DW ;

Jenkins, SG ;

Pierson, C ;

Venezia, R ;

Rihs, J ;

Iannini, P ;

Gorbach, SL ;

Snydman, DR .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (02) :208-213

[7] Susceptibility of the Bacteroides fragilis group to newer quinolones and other standard anti-anaerobic agents [J].

Horn, R ;

Robson, HG .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (01) :127-130

[8] In vitro activities of tigecycline against the Bacteroides fragilis group [J].

Jacobus, NV ;

McDermott, LA ;

Ruthazer, R ;

Snydman, DR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (03) :1034-1036

[9] In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains [J].

Katsandri, Anastasia ;

Avlamis, Athina ;

Pantazatou, Angeliki ;

Petrikkos, Georgios L. ;

Legakis, Nicholas J. ;

Papaparaskevas, Joseph .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 55 (03) :231-236

[10] Reemergence of anaerobic bacteremia [J].

Lassmann, Britta ;

Gustafson, Daniel R. ;

Wood, Christina M. ;

Rosenblatt, Jon E. .

CLINICAL INFECTIOUS DISEASES, 2007, 44 (07) :895-900

← 1 2 →